HALBT Partnerships

Partnerships Built Around Single-Cell Protein Innovation

HALBT is a science-led single-cell protein technology company developing novel SCP systems and innovation-led production technologies with strong long-term market relevance.

The company is building a focused technology platform designed for meaningful engagement with aligned partners across research, industry, commercial development, and strategic growth. HALBT’s partnership approach is shaped by innovation depth, clear market direction, and a strong commitment to building future-facing value in the SCP sector.

Strategic engagement with HALBT

HALBT is positioned for partnership with organisations that recognise the long-term importance of next-generation protein systems, innovation-led feed development, and stronger biological production technologies. The company’s focused SCP direction creates a clear foundation for high-value engagement where scientific capability, technical differentiation, and future commercial relevance intersect.

Partnership with HALBT is built around more than interest in a sector. It is built around alignment with a defined technology direction, a strong innovation platform, and a company focused on creating meaningful long-term value through novel SCP systems.

Why partner with HALBT

HALBT offers a focused and compelling platform for aligned engagement within the emerging single-cell protein space.

Focused Technology Direction

HALBT is built around a clear and disciplined SCP strategy, giving partners a strong point of alignment with a company that knows where it is going and what it is building.

Differentiated Innovation

The company’s work is centred on novel microbial protein systems and innovative platform development, including a clear emphasis on original architecture and integrated technical thinking.

Market Relevance

HALBT’s technology direction aligns with growing demand for future feed innovation, stronger biological production pathways, and next-generation protein solutions.

Long-Term Platform Value

The company is building not only a flagship SCP Program, but a broader innovation platform that supports deeper capability, stronger positioning, and greater future opportunity.

HALBT is positioned to engage with aligned organisations and stakeholders that can contribute to, strengthen, or benefit from the company’s technology direction.

Who HALBT works with

Research and Development Partners

Research groups, institutions, and technical collaborators aligned with microbial innovation, SCP development, and applied biological systems.

Commercial and Industry Partners

Businesses operating across feed, biotechnology, and related production sectors that see value in future-facing protein technologies and applied innovation.

Strategic Development Partners

Organisations interested in working with HALBT on structured technology engagement, capability alignment, and long-term development opportunity.

Capital and Growth-Aligned Stakeholders

Stakeholders seeking exposure to focused, innovation-led technology platforms positioned within an important and growing sector.

Partnership pathways

HALBT welcomes engagement across a range of aligned pathways where strategic fit, innovation value, and future relevance come together.

Technology Collaboration

Engagement around HALBT’s SCP Program, innovation platform, and related technology direction.

Research Alignment

Collaboration with groups pursuing complementary scientific, technical, or development objectives.

Commercial Engagement

Strategic discussions around future market relevance, application pathways, and technology-led opportunity.

Long-Term Strategic Partnership

Aligned engagement focused on deeper collaboration, platform value creation, and growth-oriented opportunity.

A strong platform for long-term opportunity

HALBT’s value as a partner comes from the combination of focused SCP innovation, broader platform depth, and clear market direction. The company is building a technology profile that is technically serious, commercially relevant, and well positioned within the future of protein and biological production.

Its flagship SCP Program and broader Innovation Platform together create a stronger basis for engagement than a single concept alone. This gives partners a clearer opportunity to align with a company developing novel systems, meaningful technical direction, and long-term strategic relevance in an important sector.

Start the conversation

HALBT is open to discussions with aligned partners who recognise the value of focused SCP innovation and future-facing technology development. If your organisation is interested in strategic engagement, research alignment, commercial discussion, or long-term opportunity, we welcome the conversation.